WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |

Search International and National Patent Collections
World Intellectual Property Organization
Machine translation
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/022994    International Application No.:    PCT/GB2000/003758
Publication Date: 05.04.2001 International Filing Date: 02.10.2000
Chapter 2 Demand Filed:    26.04.2001    
A61K 39/095 (2006.01), C07K 16/12 (2006.01)
Applicants: ISIS INNOVATION LIMITED [GB/GB]; Ewert House, Ewert Place, Summertown, Oxford, Oxfordshire OX2 7BZ (GB) (For All Designated States Except US).
PLESTED, Joyce, Susan [GB/GB]; (GB) (For US Only).
JENNINGS, Michael, Paul [AU/AU]; (AU) (For US Only).
GIDNEY, Margaret, Ann, Jaqueline [CA/CA]; (CA) (For US Only).
COX, Andrew, David [GB/CA]; (CA) (For US Only).
RICHARDS, James, Clare [CA/CA]; (CA) (For US Only).
MOXON, Richard, Edward [GB/GB]; (GB) (For US Only)
Inventors: PLESTED, Joyce, Susan; (GB).
JENNINGS, Michael, Paul; (AU).
GIDNEY, Margaret, Ann, Jaqueline; (CA).
COX, Andrew, David; (CA).
RICHARDS, James, Clare; (CA).
MOXON, Richard, Edward; (GB)
Agent: RUFFLES, Graham, Keith; Marks & Clerk, 57-60 Lincoln's Inn Fields, London WC2A 3LS (GB)
Priority Data:
60/156,940 30.09.1999 US
60/196,305 12.04.2000 US
Abstract: front page image
(EN)The invention relates to a vaccine for the treatment of disease caused by Neisseria, the vaccine comprising one or more immunogenic components for Neisseria serogroups, as well as antibodies to the immunogenic components and methods of preventing and treating Neisseria infections. The immunogens are based on elements of the inner core lipopolysaccharide.
(FR)L'invention concerne un vaccin utilisé pour traiter une affection causée par Neisseria. Ce vaccin comprend un ou plusieurs composants immunogènes pour les sérogroupes Neisseria, ainsi que des anticorps aux composants immunogènes et des procédés de prévention et de traitement des infections de Neisseria. Les immunogènes sont à base d'éléments du noyau interne de lipopolysaccharide.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)